The Impact of Training With Whole Body-EMS
Study Details
Study Description
Brief Summary
Researchers are trying to find out what impact training with whole body-EMS (Electronic muscle stimulation) has on various health outcomes.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
All subjects in both groups who enroll into this study will undergo an assessment of peripheral endothelial function with reactive hyperemia-peripheral arterial tonometry (RH-PAT) testing using EndoPAT; an assessment of vital signs including heart rate, blood pressure, weight, height and body mass index; laboratory blood work; cardiorespiratory testing using treadmill testing to determine VO2 max and maximal tolerated heart rate; maximal strength and maximal power testing on chest press and leg press testing; and percent body fat and fat distribution testing at baseline, and at 16-weeks follow-up (immediately after completing a 16-week training program using whole body-EMS). Baseline cardiovascular risk factors will be assessed by subject questionnaire and verified by chart review. In addition, subjects will complete an angina/chest pain symptom questionnaire (Rose Questionnaire), quality of life questionnaire (LASA Questionnaire), depression questionnaire (Patient Health Questionaire-9) and perceived stress questionnaire (Perceived Stress Scale) to assess for psychosocial wellness at each point in the study.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: EMS Group - Experimental EMS device will be turned on during exercise for this group. |
Device: EMS Device On
The EMS Device will turned on during exercise as opposed to it being turned off for control group.
|
| Placebo Comparator: EMS Group - Control EMS device will be turned off during exercise for this group. |
Other: EMS Device Off
The EMS Device will turned off during exercise as opposed to it being turned off for control group.
|
Outcome Measures
Primary Outcome Measures
- Impact of EMS on EndoPAT [16 weeks]
To assess the impact of training with whole body-EMS for a 16-week period of time, involving 1.0 x 20 minute training sessions per week, on peripheral endothelial function as measured using EndoPAT.
Secondary Outcome Measures
- Impact of EMS on BMI [16 weeks]
To assess the impact of training with whole body-EMS for a 16-week period of time, involving 1.0 x 20 minute training sessions per week, on:i) Body mass index, waist circumference, percentage body fat and distribution, and blood pressure
- Impact of EMS on Serum Lipid Profile [16 weeks]
To assess the impact of training with whole body-EMS for a 16-week period of time, involving 1.0 x 20 minute training sessions per week to Serum lipid profile
- Impact of EMS on VO2 [16 weeks]
To assess the impact of training with whole body-EMS for a 16-week period of time, involving 1.0 x 20 minute training sessions per week, on:iii) VO2 maximum (Cardiopulmonary exercise testing parameters
- Impact of EMS on Maximum Strength & Power in Chest Press and Leg Press [16 weeks]
To assess the impact of training with whole body-EMS for a 16-week period of time, involving 1.0 x 20 minute training sessions per week, on:iv) Maximum strength and maximum power in chest press and leg press
- Impact of EMS on Angina [16 weeks]
To assess the impact of training with whole body-EMS for a 16-week period of time, involving 1.0 x 20 minute training sessions per week, on:v) Symptoms of angina as measured by the Rose Questionnaire
- Impact of EMS to Longitudinal Amsterdam Aging Study Questionnaire [16 weeks]
To assess the impact of training with whole body-EMS for a 16-week period of time, involving 1.0 x 20 minute training sessions per week, on:vi) Quality of life as measured by the Longitudinal Amsterdam Aging Study Questionnaire, with values of 0-10 (0 being as bad as it can be and 10 being as good as it can be)
- Impact of EMS on Creatinine [16 weeks]
To assess the impact of training with whole body-EMS for a 16-week period of time, involving 1.0 x 20 minute training sessions per week, on:vii) Temporal changes in blood levels of creatinine kinase
- Impact of EMS to Perceived Stress Scale [16 weeks]
To assess the impact of training with whole body-EMS for a 16-week period of time, involving 1.0 x 20 minute training sessions per week, on symptoms of stress as measured on the Perceived Stress Scale with values of 0 to 4, with 0 being never stressed and 4 being very often stressed.
- Impact of EMS to Patient Health Questionnaire [16 weeks]
To assess the impact of training with whole body-EMS for a 16-week period of time, involving 1.0 x 20 minute training sessions per week on Quality of life as measured by the Patient Health Questionnaire with a score of 0-27; 0 being no depression and 27 being severe depression.
- Impact of EMS on Blood Glucose [16 weeks]
To assess the impact of training with whole body-EMS for a 16-week period of time, involving 1.0 x 20 minute training sessions per week on Blood Glucose
- Impact of EMS on HbA1c [16 weeks]
To assess the impact of training with whole body-EMS for a 16-week period of time, involving 1.0 x 20 minute training sessions per week on HbA1c
- Impact of EMS on High-Sensitivity CRP [16 weeks]
To assess the impact of training with whole body-EMS for a 16-week period of time, involving 1.0 x 20 minute training sessions per week on high-sensitivity CRP
- Impact of EMS on Uric Acid [16 weeks]
To assess the impact of training with whole body-EMS for a 16-week period of time, involving 1.0 x 20 minute training sessions per week on uric acid.
- Impact of EMS on Fibrinogen [16 weeks]
To assess the impact of training with whole body-EMS for a 16-week period of time, involving 1.0 x 20 minute training sessions per week on fibrinogen
- Impact of EMS on Homocysteine [16 weeks]
To assess the impact of training with whole body-EMS for a 16-week period of time, involving 1.0 x 20 minute training sessions per week on homocysteine.
- Impact of EMS on Lipoprotein [16 weeks]
To assess the impact of training with whole body-EMS for a 16-week period of time, involving 1.0 x 20 minute training sessions per week on lipoprotein.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Healthy individuals
-
Employees at the Mayo Clinic, Rochester MN
Exclusion Criteria:
-
Subjects under the age of 18
-
Pregnant women
-
Subjects with a history of liver or kidney disease, acute illness, taking medications (such as glucocorticoids)
-
Subjects who have conditions (such as chronic inflammatory muscular diseases or Cushing's syndrome) that affect muscle mass
-
Individuals with pacemakers and implantable cardiac defibrillators
-
Individuals who conduct any other type of resistance training (> 45 minutes/week)
-
Individuals who have regular "high" alcohol consumption (> 80g/day on 5 days a week)
-
Subjects unable to consent to or participate in the 16-week EMS intervention or be available for follow up
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Mayo Clinic | Rochester | Minnesota | United States | 55905 |
Sponsors and Collaborators
- Mayo Clinic
Investigators
- Principal Investigator: Amir Lerman, MD, Mayo Clinic
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- 19-003449